CAS 2237268-08-3

Fórmula: C19H22N4O4S

InChI: InChI=1S/C19H22N4O4S/c24-19(21-11-14-7-9-20-10-8-14)22-15-1-5-18(6-2-15)28(25,26)23-12-16-3-4-17(13-23)27-16/h1-2,5-10,16-17H,3-4,11-13H2,(H2,21,22,24)

Chave InChI: KTSOHNHLOLGQCY-UHFFFAOYSA-N

SMILES: C1CC2CN(CC1O2)S(=O)(=O)C3=CC=C(C=C3)NC(=O)NCC4=CC=NC=C4

SBI-797812

CAS: 2237268-08-3

SBI-797812 is structurally similar to active-site directed inhibitor of NAMPT(NAMPT with EC50 of 0.37 μM).

Fórmula: C₁₉H₂₂N₄O₄S

Pureza: 99.31%

Cor e Forma: White Solid

Peso molecular: 402.467

Ref: TM-T12854

SBI-797812

CAS: 2237268-08-3

SBI-797812

Fórmula: C₁₉H₂₂N₄O₄S

Pureza: ≥98%

Peso molecular: 402.47

Ref: 54-BUP04673

1-(4-((8-Oxa-3-azabicyclo[3.2.1]octan-3-yl)sulfonyl)phenyl)-3-(pyridin-4-ylmethyl)urea

CAS: 2237268-08-3

Pureza: 98%

Ref: IN-DA01V441

SBI-797812

CAS: 2237268-08-3

1-(4-((8-Oxa-3-azabicyclo[3.2.1]octan-3-yl)sulfonyl)phenyl)-3-(pyridin-4-ylmethyl)urea

Fórmula: C₁₉H₂₂N₄O₄S

Pureza: 98%

Peso molecular: 402.47

Ref: IN-DG01141462

SBI-797812

CAS: 2237268-08-3

SBI-797812 is a small molecule that targets the cellular protein, stabilin-1. It has been shown to suppress the degradation of stabilin-1 and stabilize it in cells from animals and humans. When this drug binds to stabilin-1, it prevents the binding of destabilizing molecules and increases the stability of stabilin-1. This drug also has been shown to boost levels of stabilin-1 in tissues from mice by increasing the biosynthesis of mononucleotides. SBI-797812 has potential as a treatment for diseases such as Parkinson's disease, Alzheimer's disease, Huntington's disease, and amyotrophic lateral sclerosis.

Fórmula: C₁₉H₂₂N₄O₄S

Pureza: Min. 95%

Peso molecular: 402.47 g/mol

Ref: 3D-MPD26808